Literature DB >> 33528814

Life expectancy of HIV-infected patients followed at the largest hospital in Guinea-Bissau is one-fourth of life expectancy of the background population.

Thomas Engell-Sørensen1,2, Andreas Rieckmann3,4, Candida Medina5, David da Silva Té5, Amabelia Rodrigues6, Ane Bærent Fisker6,3,7, Peter Aaby6,3, Christian Erikstrup8, Sanne Jespersen6,9, Christian Wejse6,9,10, Bo Langhoff Hønge6,9,8.   

Abstract

PURPOSE: To estimate the life expectancy (LE) of HIV-infected patients in the West African country Guinea-Bissau and compare it with the background population.
METHODS: Using data from the largest HIV outpatient clinic at the Hospital Nacional Simão Mendes in the capital Bissau, a retrospective observational cohort study was performed. The study included patients attending the clinic between June 2005 and January 2018. A total of 8958 HIV-infected patients were included. In the analysis of the background population, a total of 109,191 people were included. LE incorporating loss to follow-up (LTFU) was estimated via Kaplan-Meier estimators using observational data on adult HIV-infected patients and background population.
RESULTS: The LE of 20-year-old HIV-infected patients was 9.8 years (95% CI 8.3-11.5), corresponding to 22.3% (95% CI 18.5-26.7%) of the LE of the background population. (LE for 20-year-olds in the background population was 44.0 years [95% CI 43.0-44.9].) Patients diagnosed with CD4 cell counts below 200 cells/µL had a LE of 5.7 years (95% CI 3.6-8.2). No increase in LE with later calendar period of diagnosis was observed.
CONCLUSIONS: LE was shown to be markedly lower among HIV-infected patients compared with the background population. While other settings have shown marked improvements in prognosis of HIV-infected patients in recent years, no improvement in Bissau was observed over time (9.8 years (95% CI 7.6-12.2) and 9.9 years (95% CI 7.6-12.1) for the periods 2005-2010 and 2014-2016, respectively).
© 2021. Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Guinea-Bissau; HIV; HIV-2; Life expectancy; Loss to follow-up; Mortality

Year:  2021        PMID: 33528814     DOI: 10.1007/s15010-020-01574-6

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  31 in total

1.  Barriers and facilitators to antiretroviral therapy adherence among patients with HIV in Bissau, Guinea-Bissau: A qualitative study.

Authors:  Dlama N Rasmussen; David da Silva Té; Lotte Rodkjaer; Inés Oliveira; Candida Medina; Toke Barfod; Alex L Laursen; Peter Aaby; Morten Sodemann; Christian Wejse
Journal:  Afr J AIDS Res       Date:  2013-07-26       Impact factor: 1.300

2.  Nonadherence is Associated with Lack of HIV-Related Knowledge: A Cross-Sectional Study among HIV-Infected Individuals in Guinea-Bissau.

Authors:  Charlotte Dyrehave; Dlama Nggida Rasmussen; Bo Langhoff Hønge; Sanne Jespersen; Faustino Gomes Correia; Candida Medina; Christian Wejse; Lotte Rodkjaer
Journal:  J Int Assoc Provid AIDS Care       Date:  2015-08-21

3.  Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.

Authors:  Edward J Mills; Celestin Bakanda; Josephine Birungi; Keith Chan; Nathan Ford; Curtis L Cooper; Jean B Nachega; Mark Dybul; Robert S Hogg
Journal:  Ann Intern Med       Date:  2011-07-18       Impact factor: 25.391

4.  HIV-2 continues to decrease, whereas HIV-1 is stabilizing in Guinea-Bissau.

Authors:  Jens S Olesen; Sanne Jespersen; Zacarias J da Silva; Amabélia Rodrigues; Christian Erikstrup; Peter Aaby; Christian Wejse; Bo L Hønge
Journal:  AIDS       Date:  2018-06-01       Impact factor: 4.177

5.  Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study.

Authors:  Sabin Nsanzimana; Eric Remera; Steve Kanters; Keith Chan; Jamie I Forrest; Nathan Ford; Jeanine Condo; Agnes Binagwaho; Edward J Mills
Journal:  Lancet Glob Health       Date:  2015-03       Impact factor: 26.763

6.  Implementation and Operational Research: Effect of Universal Access to Antiretroviral Therapy on HIV/AIDS Mortality in Mexico 1990-2011.

Authors:  Juan E Hernández-Ávila; Lina S Palacio-Mejía; Alfonso Hernández-Romieu; Sergio Bautista-Arredondo; Jaime Sepúlveda Amor; Mauricio Hernández-Ávila
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

7.  Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.

Authors:  Aysel Gueler; André Moser; Alexandra Calmy; Huldrych F Günthard; Enos Bernasconi; Hansjakob Furrer; Christoph A Fux; Manuel Battegay; Matthias Cavassini; Pietro Vernazza; Marcel Zwahlen; Matthias Egger
Journal:  AIDS       Date:  2017-01-28       Impact factor: 4.177

8.  Adult life expectancy trends in the era of antiretroviral treatment in rural Uganda (1991-2012).

Authors:  Gershim Asiki; Georges Reniers; Robert Newton; Kathy Baisley; Jessica Nakiyingi-Miiro; Emma Slaymaker; Ivan Kasamba; Janet Seeley; Jim Todd; Pontiano Kaleebu; Anatoli Kamali
Journal:  AIDS       Date:  2016-01-28       Impact factor: 4.177

9.  Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.

Authors:  Margaret May; Jonathan A C Sterne; Caroline Sabin; Dominique Costagliola; Amy C Justice; Rodolphe Thiébaut; John Gill; Andrew Phillips; Peter Reiss; Robert Hogg; Bruno Ledergerber; Antonella D'Arminio Monforte; Norbert Schmeisser; Shlomo Staszewski; Matthias Egger
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

10.  Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.

Authors:  Leigh F Johnson; Joel Mossong; Rob E Dorrington; Michael Schomaker; Christopher J Hoffmann; Olivia Keiser; Matthew P Fox; Robin Wood; Hans Prozesky; Janet Giddy; Daniela Belen Garone; Morna Cornell; Matthias Egger; Andrew Boulle
Journal:  PLoS Med       Date:  2013-04-09       Impact factor: 11.069

View more
  1 in total

1.  Oral Polio Vaccine to Mitigate the Risk of Illness and Mortality During the Coronavirus Disease 2019 Pandemic: A Cluster-Randomized Trial in Guinea-Bissau.

Authors:  Ane B Fisker; Justiniano S D Martins; Line M Nanque; Andreas M Jensen; Elsi J C Ca; Sebastian Nielsen; Cesario L Martins; Amabelia Rodrigues
Journal:  Open Forum Infect Dis       Date:  2022-09-11       Impact factor: 4.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.